Literature DB >> 21571962

Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

Prashant Tembhare1, Constance M Yuan, Liqiang Xi, John C Morris, David Liewehr, David Venzon, John E Janik, Mark Raffeld, Maryalice Stetler-Stevenson.   

Abstract

Flow cytometric T-cell receptor (TCR)-V(β) repertoire analysis (TCR-V(β)-R) is a sensitive method for detection of T-cell clonality; however, no uniform approach exists to define clonality in neoplastic T cells. TCR-V(β)-R was evaluated in patients with a diagnosis of T-cell neoplasia in initial diagnostic specimens from 41 patients and for minimal residual disease (MRD) monitoring in 61 sequential samples from 14 patients with mature T-cell neoplasia. Gating strategies and criteria for detection of T-cell clonality were determined. In all 41 initial specimens, T-cell clonality was demonstrated via TCR-V(β)-R. The frequency of V(β) usage was consistent with random neoplastic transformation of TCR-V(β) subsets. MRD was successfully detected in follow-up samples from all 14 patients evaluated, Furthermore, MRD after therapy was quantitated in 48 peripheral blood specimens. TCR-V(β)-R analysis is a sensitive method for detection of T-cell clonality and is useful for diagnosis and MRD detection in multiple specimen types.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571962      PMCID: PMC7384354          DOI: 10.1309/AJCPV2D1DDSGJDBW

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  24 in total

1.  Flow cytometric analysis of the Vbeta repertoire in healthy controls.

Authors:  R van den Beemd; P P Boor; E G van Lochem; W C Hop; A W Langerak; I L Wolvers-Tettero; H Hooijkaas; J J van Dongen
Journal:  Cytometry       Date:  2000-08-01

2.  Variables affecting the quantitation of CD22 in neoplastic B cells.

Authors:  Gregory A Jasper; Indu Arun; David Venzon; Robert J Kreitman; Alan S Wayne; Constance M Yuan; Gerald E Marti; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-09-24       Impact factor: 3.058

3.  Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia.

Authors:  G A Neale; E Coustan-Smith; Q Pan; X Chen; B Gruhn; P Stow; F G Behm; C H Pui; D Campana
Journal:  Leukemia       Date:  1999-08       Impact factor: 11.528

4.  Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating.

Authors:  Taiji Yokote; Toshikazu Akioka; Satoko Oka; Satoshi Hara; Kichinosuke Kobayashi; Hideto Nakajima; Takeshi Yamano; Toshiyuki Ikemoto; Akira Shimizu; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Am J Clin Pathol       Date:  2005-08       Impact factor: 2.493

5.  Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells.

Authors:  Indu Arun; Jacqueline A Wulu; John E Janik; Gregory A Jasper; Constance M Yuan; David Venzon; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-05       Impact factor: 3.058

Review 6.  The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

Authors:  Adhra Al-Mawali; David Gillis; Ian Lewis
Journal:  Am J Clin Pathol       Date:  2009-01       Impact factor: 2.493

7.  A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene.

Authors:  K P McCarthy; J P Sloane; J H Kabarowski; E Matutes; L M Wiedemann
Journal:  Diagn Mol Pathol       Date:  1992-09

8.  Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies.

Authors:  Rose C Beck; Steve Stahl; Christine L O'Keefe; Jaroslaw P Maciejewski; Karl S Theil; Eric D Hsi
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

9.  International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.

Authors:  A C Rawstron; N Villamor; M Ritgen; S Böttcher; P Ghia; J L Zehnder; G Lozanski; D Colomer; C Moreno; M Geuna; P A S Evans; Y Natkunam; S E Coutre; E D Avery; L Z Rassenti; T J Kipps; F Caligaris-Cappio; M Kneba; J C Byrd; M J Hallek; E Montserrat; P Hillmen
Journal:  Leukemia       Date:  2007-03-15       Impact factor: 11.528

10.  Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques.

Authors:  William G Morice; Teresa Kimlinger; Jerry A Katzmann; John A Lust; Paul J Heimgartner; Kevin C Halling; Curtis A Hanson
Journal:  Am J Clin Pathol       Date:  2004-03       Impact factor: 2.493

View more
  10 in total

1.  Flow cytometric immunophenotypic assessment of T-cell clonality by vβ repertoire analysis in fine-needle aspirates and cerebrospinal fluid.

Authors:  Prashant Tembhare; Constance M Yuan; John C Morris; John E Janik; Armando C Filie; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2012-02       Impact factor: 2.493

2.  Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.

Authors:  J Gauthier; L Holmberg; D Wu; W Bensinger; A K Gopal; O Press; D Maloney; D J Green; B G Till; D Byelykh; A Shustov
Journal:  Bone Marrow Transplant       Date:  2016-10-24       Impact factor: 5.483

3.  PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data.

Authors:  Joseph A DiGiuseppe; Jolene L Cardinali; William N Rezuke; Dana Pe'er
Journal:  Cytometry B Clin Cytom       Date:  2017-09-26       Impact factor: 3.058

4.  Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens.

Authors:  Joo Y Song; Armando C Filie; David Venzon; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Cytometry B Clin Cytom       Date:  2012-07-26       Impact factor: 3.058

Review 5.  T-cell receptor signaling in peripheral T-cell lymphoma - a review of patterns of alterations in a central growth regulatory pathway.

Authors:  Kathrin Warner; Nicole Weit; Giuliano Crispatzu; Joan Admirand; Dan Jones; Marco Herling
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

6.  A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains.

Authors:  Kazutaka Kitaura; Tadasu Shini; Takaji Matsutani; Ryuji Suzuki
Journal:  BMC Immunol       Date:  2016-10-11       Impact factor: 3.615

7.  High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities.

Authors:  James M Heather; Mazlina Ismail; Theres Oakes; Benny Chain
Journal:  Brief Bioinform       Date:  2018-07-20       Impact factor: 11.622

Review 8.  Mature T-Cell leukemias: Challenges in Diagnosis.

Authors:  Dima El-Sharkawi; Ayoma Attygalle; Claire Dearden
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

9.  Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India.

Authors:  Prashant R Tembhare; Gaurav Chatterjee; Anumeha Chaturvedi; Niharika Dasgupta; Twinkle Khanka; Shefali Verma; Sitaram G Ghogale; Nilesh Deshpande; Karishma Girase; Manju Sengar; Bhausaheb Bagal; Hasmukh Jain; Dhanalaxmi Shetty; Sweta Rajpal; Nikhil Patkar; Tushar Agrawal; Sridhar Epari; Tanuja Shet; Papagudi G Subramanian; Sumeet Gujral
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

10.  Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.

Authors:  Bogdan Dumitriu; Sawa Ito; Xingmin Feng; Nicole Stephens; Muharrem Yunce; Sachiko Kajigaya; Joseph J Melenhorst; Olga Rios; Priscila Scheinberg; Fariba Chinian; Keyvan Keyvanfar; Minoo Battiwalla; Colin O Wu; Irina Maric; Liqiang Xi; Mark Raffeld; Pawel Muranski; Danielle M Townsley; Neal S Young; Austin J Barrett; Phillip Scheinberg
Journal:  Lancet Haematol       Date:  2015-12-17       Impact factor: 18.959

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.